Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Keeping the head elevated for 1.5 days after hair transplant surgery helps prevent facial swelling.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Dermatologists are crucial in providing personalized care for patients with sex development differences.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Early diagnosis and management of Sheehan's syndrome are crucial for improving quality of life and fertility.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

A 36-year-old woman with low potassium levels was found to have Cushing disease, and after treatment, her potassium levels normalized.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

Nourkrin® Woman with Marilex® improves hair growth, appearance, and confidence in women with hair loss.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.